Delirium, Dementia, Amnestic, Cognitive Disorders  >>  VQW-765  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
VQW-765 / Vanda
NCT00582855 / 2007-001846-42: Effect of AQW051 in Patients With Memory Impairment

Terminated
2
54
Canada, Europe, RoW
AQW051, Placebo
Novartis Pharmaceuticals
Mild Alzheimer's Disease, Amnestic Mild Cognitive Impairment
02/09
 

Download Options